notification

Scheduled Maintenance on Our Customer Portals

Horizon BCBSNJ's customer portals will undergo scheduled maintenance beginning at 6 p.m. Friday May 18, 2018 until 8 a.m. Monday May 21, 2018. During this time, you may experience intermittent issues with some transactions. We apologize for the inconvenience and appreciate your patience.

Notification_close

FDA issues lamotrigine (Lamictal®) warning

On April 25, 2018, the U.S. Food and Drug Administration (FDA) issued a warning that the medicine lamotrigine (Lamictal) can cause a rare but very serious reaction known as hemophagocytic lymphohistiocytosis (HLH).

Notification_close

BlueCard Announcements

Posted on January 8, 2018

Arkansas BlueCross BlueShield: Six specialty medications to need prior approval beginning April 2018

Posted on November 22, 2017

Blue Cross Blue Shield of Massachusetts: Radiology and Sleep Apnea Program Expansion

Posted on November 22, 2017

Arkansas BlueCross BlueShield: AIM Medical Oncology Program to be Implemented for Tyson Foods Enrollees

Posted on November 2, 2017

Blue Cross Blue Shield of Minnesota: Implementation of a Medical Drug Exclusions List

Posted on May 16, 2017

Blue Cross Blue Shield of Massachusetts: BCBSMA High Tech Radiology and Sleep UM Programs

Posted on May 16, 2017

Blue Cross and Blue Shield of Minnesota: New PA requirement for Nusinersen (Spinraza)